ES8403897A1 - Procedimiento para la fabricacion de nuevos derivados de la amino-3 quinuclidina - Google Patents

Procedimiento para la fabricacion de nuevos derivados de la amino-3 quinuclidina

Info

Publication number
ES8403897A1
ES8403897A1 ES524128A ES524128A ES8403897A1 ES 8403897 A1 ES8403897 A1 ES 8403897A1 ES 524128 A ES524128 A ES 524128A ES 524128 A ES524128 A ES 524128A ES 8403897 A1 ES8403897 A1 ES 8403897A1
Authority
ES
Spain
Prior art keywords
derivatives
aminoquinuclidin
preparation
therapeutical agents
new derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES524128A
Other languages
English (en)
Other versions
ES524128A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synthelabo SA
Original Assignee
Delalande SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Delalande SA filed Critical Delalande SA
Publication of ES8403897A1 publication Critical patent/ES8403897A1/es
Publication of ES524128A0 publication Critical patent/ES524128A0/es
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D453/00Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

PROCEDIMIENTO PARA LA PREPARACION DE DERIVADOS DE LA AMINO-3 QUINUCLIDINA, DE FORMULA GENERAL (I), EN LA QUE X REPRESENTA UN ATOMO DE AZUFRE O DE OXIGENO; R REPRESENTA UN ATOMO DE HIDROGENO, UN GRUPO ALQUILO O UN GRUPO BENCILO; Y AR REPRESENTA UN NUCLEO FENILO SUSTITUIDO POR UN ATOMO DE HALOGENO O UN NUCLEO FENILO, Y SUS SALES DE ADICION DE ACIDO FARMACEUTICAMENTE ACEPTABLES.CONSISTE EN CONDENSAR LOS ACIDOS DE FORMULA: AR-COOH CON LOS DERIVADOS DE LA AMINO-3 QUINUCLIDINA, DE FORMULA (II), EN LA CUAL R REPRESENTA UN ATOMO DE HIDROGENO O UN GRUPO ALQUILO DE 1A 4 ATOMOS DE CARBONO O BENCILO.DE APLICACION EN TERAPEUTICA.
ES524128A 1982-07-02 1983-07-01 Procedimiento para la fabricacion de nuevos derivados de la amino-3 quinuclidina Granted ES524128A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8211670A FR2529548A1 (fr) 1982-07-02 1982-07-02 Nouveaux derives de l'amino-3 quinuclidine, leur procede et leur application en therapeutique

Publications (2)

Publication Number Publication Date
ES8403897A1 true ES8403897A1 (es) 1984-04-16
ES524128A0 ES524128A0 (es) 1984-04-16

Family

ID=9275643

Family Applications (1)

Application Number Title Priority Date Filing Date
ES524128A Granted ES524128A0 (es) 1982-07-02 1983-07-01 Procedimiento para la fabricacion de nuevos derivados de la amino-3 quinuclidina

Country Status (9)

Country Link
US (1) US4657911A (es)
EP (1) EP0099789B1 (es)
JP (1) JPS5921684A (es)
AU (1) AU562210B2 (es)
CA (1) CA1265802A (es)
DE (1) DE3372769D1 (es)
ES (1) ES524128A0 (es)
FR (1) FR2529548A1 (es)
ZA (1) ZA834704B (es)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI74707C (fi) * 1982-06-29 1988-03-10 Sandoz Ag Foerfarande foer framstaellning av terapeutiskt anvaendbara alkylenoeverbryggade piperidylestrar eller -amider av bicykliska karboxylsyror.
JPS5936675A (ja) * 1982-07-13 1984-02-28 サンド・アクチエンゲゼルシヤフト 二環性複素環式カルボン酸アザビシクロアルキルエステルまたはアミド
US5175173A (en) * 1983-12-22 1992-12-29 Sun Jung Hui Carboxamides useful as antiemetic or antipsychotic agents
US4888353A (en) * 1986-02-28 1989-12-19 Erbamont, Inc. Carboxamides useful as antiemetic or antipsychotic agents
US4593034A (en) * 1984-04-06 1986-06-03 A. H. Robins Company, Inc. 2-alkoxy-N-(1-azabicyclo[2.2.2]oct-3-yl)benzamides and thiobenzamides
US4605652A (en) * 1985-02-04 1986-08-12 A. H. Robins Company, Inc. Method of enhancing memory or correcting memory deficiency with arylamido (and arylthioamido)-azabicycloalkanes
US4870181A (en) * 1985-02-04 1989-09-26 A. H. Robins Company, Incorporated Process for the preparation of 2-alkoxy-N-(1-azabicyclo[2.2.2])octan-3-yl)aminobenzamides
GB8511988D0 (en) * 1985-05-11 1985-06-19 Beecham Group Plc Compounds
GB8520616D0 (en) * 1985-08-16 1985-09-25 Beecham Group Plc Compounds
GB8525844D0 (en) * 1985-10-19 1985-11-20 Beecham Group Plc Compounds
US4722834A (en) * 1986-03-05 1988-02-02 A. H. Robins Company, Incorporated Method of using 2-alkoxy-N-(1-azabicyclo[2.2.2]oct-3-yl)benzamide-N-oxides to control emesis caused by anticancer drugs
US4717563A (en) * 1986-03-05 1988-01-05 A. H. Robins Company, Inc. 2-alkoxy-N-(1-azabicyclo(2.2.2)oct-3-yl) benzamides and thiobenzamides in a method for alleviating emesis caused by non-platinum anticancer drugs
HU895334D0 (en) * 1986-07-30 1990-01-28 Sandoz Ag Process for the preparation of nasal pharmaceutical compositions
US4772459A (en) * 1986-09-09 1988-09-20 Erbamont, Inc. Method for controlling emesis caused by chemotherapeutic agents and antiemetic agents useful therein
EP0272052B1 (en) * 1986-12-16 1992-07-08 A.H. ROBINS COMPANY, INCORPORATED (a Delaware corporation) Anxiolytic-N-(1-Azabicyclo[2.2.2]Oct-3-yl) Benzamides and Thobenzamides
US5246941A (en) 1986-12-17 1993-09-21 Glaxo Group Limited Method for the treatment of depression
FR2610323B1 (fr) * 1987-02-04 1989-06-23 Delalande Sa Enantiomeres de configuration absolue s de derives amide de l'amino-3 quinuclidine, leur procede de preparation et leur application en therapeutique
US5237066A (en) * 1987-02-04 1993-08-17 Delande S.A. Enantiomers of absolute configuration S of amide derivatives of 3-aminoquinuclidine, the process for preparing them and their application in therapy
GB8718345D0 (en) * 1987-08-03 1987-09-09 Fordonal Sa N-substituted benzamides
GB8720805D0 (en) * 1987-09-04 1987-10-14 Naylor R J 2-alkoxy-n-(1-azabicyclo(2 2 2)oct-3-yl)benzamides & thiobenzamides
EP0311724A1 (en) * 1987-10-16 1989-04-19 Synthelabo Anxiolytic-R-N-(1-azabicyclo[2.2.2]oct-3-yl) benzamides and thiobenzamides
FR2625678B1 (fr) * 1988-01-13 1991-06-07 Delalande Sa Agents anorexigenes a base de n-(quinuclidin-3-yl)-benzamides ou thiobenzamides
US4863919A (en) * 1988-02-01 1989-09-05 A. H. Robins Company, Incorporated Method of enhancing memory or correcting memory deficiency with arylamido(and arylthiomido)-azabicycloalkanes
DE3878235T2 (de) * 1988-08-04 1993-06-03 Synthelabo Antischizophren-wirksame s-n-(1-azabicyclo (2.2.2.)oct-3-yl)benzamide und thiobenzamide.
WO1990005525A1 (en) * 1988-11-23 1990-05-31 Pfizer Inc. Quinuclidine derivatives as substance p antagonists
GB8904551D0 (en) * 1989-02-28 1989-04-12 Glaxo Group Ltd Chemical compounds
US5290938A (en) * 1989-09-15 1994-03-01 Chiron Laboratories A.S. Preparation of S-(-)- and R-(+)-N-(quinuclidinyl-3)-amide
NO168529C (no) * 1989-09-15 1992-03-04 Chiron Lab As Fremgangsmaate for fremstilling av s-(-) og r-(+)-n-(quinuclidinyl-3)-amider.
US5070095A (en) * 1990-12-12 1991-12-03 A. H. Robins Company, Incorporated Substituted 4-(amidino)benzamides of 1-azabicyclo[2.2.2]octan-3- and -4-amine as gastric prokinetic, antiemetic, and anxiolytic agents
GB9027487D0 (en) * 1990-12-19 1991-02-06 Beecham Group Plc Pharmaceuticals
US5084460A (en) * 1990-12-24 1992-01-28 A. H. Robins Company, Incorporated Methods of therapeutic treatment with N-(3-ouinuclidinyl)-2-hydroxybenzamides and thiobenzamides
US5138060A (en) * 1991-01-03 1992-08-11 Pfizer Inc. Process and intermediates for preparing azabicyclo(2.2.2)octan-3-imines
US5273972A (en) * 1992-03-26 1993-12-28 A. H. Robins Company, Incorporated [(2-diakylaminomethyl)-3-quinuclidinyl]-benzamides and benzoates
US5236931A (en) * 1992-03-26 1993-08-17 A. H. Robins Company, Incorporated 2-substituted benzamide and benzoate derivatives of 3-aminoquinuclidine and 3-quinuclidinol
FR2719842B1 (fr) * 1994-05-10 1996-06-07 Synthelabo Sels quaternaires de dérivés de 1-azabicyclo [2.2.2] octane, leur préparation et leur application en thérapeutique.
US5723103A (en) * 1994-12-09 1998-03-03 Vanderbilt University Substituted benzamides and radioligand analogs and methods of use
SE0000540D0 (sv) * 2000-02-18 2000-02-18 Astrazeneca Ab New compounds
JP2004506735A (ja) 2000-08-18 2004-03-04 ファルマシア・アンド・アップジョン・カンパニー 疾患治療用キヌクリジン置換アリール化合物
AU2001282873A1 (en) 2000-08-18 2002-03-04 Pharmacia And Upjohn Company Quinuclidine-substituted aryl compounds for treatment of disease
US6492385B2 (en) 2000-08-18 2002-12-10 Pharmacia & Upjohn Company Quinuclidine-substituted heteroaryl moieties for treatment of disease
WO2002015662A2 (en) 2000-08-21 2002-02-28 Pharmacia & Upjohn Company Quinuclidine-substituted heteroaryl moieties for treatment of disease (nicotinic acetylcholine receptor antagonists
WO2002017358A2 (en) 2000-08-21 2002-02-28 Pharmacia & Upjohn Company Quinuclidine-substituted heteroaryl moieties for treatment of disease (nicotinic acetylcholine receptor antagonists)
PE20021019A1 (es) 2001-04-19 2002-11-13 Upjohn Co Grupos azabiciclicos sustituidos
JP2005504059A (ja) * 2001-08-24 2005-02-10 ファルマシア アンド アップジョン カンパニー リミティド ライアビリティー カンパニー 疾患を処置するための置換アリール7−アザ[2.2.1]ビシクロヘプタン
JP2005522456A (ja) 2002-02-15 2005-07-28 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー Cns関連障害治療のためのアザビシクロ置換ベンゾイルアミドおよびチオアミド
EP1478646A1 (en) * 2002-02-20 2004-11-24 PHARMACIA & UPJOHN COMPANY Azabicyclic compounds with alfa7 nicotinic acetylcholine receptor activity
JP2005537297A (ja) 2002-08-01 2005-12-08 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー アルファ−7nachr活性を有する1h−ピラゾールおよび1h−ピロール−アザビシクロ化合物
JP2007515478A (ja) * 2003-12-22 2007-06-14 アストラゼネカ・アクチエボラーグ ニコチン性アセチルコリンレセプターリガンド
WO2008028903A2 (en) 2006-09-04 2008-03-13 Neurosearch A/S Pharmaceutical combinations of a nicotine receptor modulator and a cognitive enhancer
WO2008119710A1 (en) * 2007-03-30 2008-10-09 Neurosearch A/S Two-phase test method for characterizing the effect of a chemical compound on a test animal and maze for carrying out the method
ES2432618T3 (es) 2009-05-20 2013-12-04 Inserm (Institut National De La Santé Et De La Recherche Medicale) Antagonistas del receptor 5-HT3 de serotonina para usar en el tratamiento o prevención de una patología del oído interno con déficit vestibular
JP5955767B2 (ja) 2009-05-20 2016-07-20 インセルム(インスティチュート ナショナル デ ラ サンテ エ デ ラ リシェルシェ メディカル) 損傷性前庭障害の処置における使用のためのセロトニン5−ht3受容体拮抗薬

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE331841B (es) * 1967-05-23 1971-01-18 Astra Ab
US3534053A (en) * 1967-05-24 1970-10-13 American Home Prod Quinuclidine derivatives
US3702324A (en) * 1970-06-24 1972-11-07 Stanford Research Inst 3,4,5-trimethoxybenzamides of substituted anilines and of alkylpiperidines
FR2183565B1 (es) * 1972-05-10 1975-12-26 Cerm Cent Europ Rech Mauvernay
CH614709A5 (es) * 1975-09-25 1979-12-14 Ciba Geigy Ag
NL7611713A (nl) * 1975-11-03 1977-05-05 Thomae Gmbh Dr K Werkwijze voor de bereiding van verbindingen en preparaten met waardevolle farmacologische eigen- schappen.
FR2329226A1 (fr) * 1975-11-03 1977-05-27 Ipa Ind Plastique Aquitain Porte-documents ou pochette
US4203989A (en) * 1979-04-30 1980-05-20 G. D. Searle & Co. Anti-diarrheal diaryl-(1-azabicyclo(2.2.2)octan-2-yl)-alkanols and related compounds

Also Published As

Publication number Publication date
FR2529548B1 (es) 1985-04-19
AU562210B2 (en) 1987-06-04
CA1265802A (en) 1990-02-13
JPH0587516B2 (es) 1993-12-16
EP0099789B1 (fr) 1987-07-29
FR2529548A1 (fr) 1984-01-06
ZA834704B (en) 1984-03-28
AU1650783A (en) 1984-01-05
US4657911A (en) 1987-04-14
JPS5921684A (ja) 1984-02-03
ES524128A0 (es) 1984-04-16
DE3372769D1 (en) 1987-09-03
EP0099789A1 (fr) 1984-02-01

Similar Documents

Publication Publication Date Title
ES8403897A1 (es) Procedimiento para la fabricacion de nuevos derivados de la amino-3 quinuclidina
MX9701292A (es) Compuestos espiro-azabiciclicos utiles en la terapia.
ES8500056A1 (es) Procedimiento para la preparacion de derivados de imidazol.
ES8504143A1 (es) Procedimiento para la obtencion de dihidropirimidinas
EP0034473A3 (en) Substituted imidazoles, their preparation, pharmaceutical compositions containing the same and their use in therapy
ES8702371A1 (es) Un procedimiento para preparar nuevos derivados de 6-(4-fenilo sustituido -3(2h) piradazinona.
ES8102561A1 (es) Procedimiento de preparacion de los aril-1 arilsulfonil-4 a amino-propoxi-3 1h pirazoles
DE3566545D1 (en) 2-substituted-1,3-propylidenediphosphonate derivatives, the process for their preparation and pharmaceutical compositions containing them
TW261616B (es)
ES8706654A1 (es) Un procedimiento para la preparacion de nuevos derivados de benzotiazina
EP0132764A3 (en) New compounds derived from diphenyl-methylene-ethylamine
ES8605507A1 (es) Un compuesto de 3-indolcarboxamida
ES8500226A1 (es) Un procedimiento de preparacion de imino-2-pirrolidinas.
ES8105992A1 (es) Un procedimiento para la preparacion de fenil-quinolicidinas
ES8604520A1 (es) Procedimiento para preparar derivados de 2(1h)-piridona
ES8300332A1 (es) Un procedimiento para la preparacion de nuevos derivados de imidazoquinazolinas
ES8506641A1 (es) Procedimiento para preparar 1-acetonil-2-(fenilimino)-imidazolidinas
DE3374005D1 (en) 1-methyl-5-nitro-imidazoline derivatives and therapeutic compositions which contain them as active principle
ES8800156A1 (es) Procedimiento para preparar nuevos derivados 3-piridilmetilnaftilicos
IL71881A (en) Substituted 1,2,3-triazino (4'5':4,5)thieno(2-3-b)quinolin-4(3h)-ones,their preparation and antiallergic pharmaceutical compositions containing them
IL83088A (en) Substituted 3-isoquinolinols,their preparation and pharmaceutical compositions containing them
ES8401952A1 (es) Un procedimiento para preparar nuevos derivados de 1,4-benzotiazina.
ES8602676A1 (es) Un procedimiento para la preparacion de nuevos derivados de pirrolo-(2,1-a)isoquilonina.
ES8506310A1 (es) N-oxidos de derivados aminociclicos
PT83307B (en) Spirobenzofuran-2 (3h),1'-cycloheptanes a process and interme diates for their preparation and their use as medicaments

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20040214